nach oben

Erschienen in:

17.10.2016 | Herzinsuffizienz | CME

Depression und Herzinsuffizienz – doppeltes Risiko?

Diagnostik, prognostische Bedeutung und Therapie einer unterschätzten Komorbidität

verfasst von: J. Wallenborn, Prof. Dr. med. C. E. Angermann

Erschienen in: Herz | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Herzinsuffizienz und Depression sind Volkskrankheiten von besonderer klinischer und ökonomischer Relevanz. Verglichen mit der Normalbevölkerung findet sich bei Patienten mit Herzinsuffizienz eine komorbide Depression bis zu 5‑mal häufiger. Dies hat negative Auswirkungen auf die Morbidität, Mortalität, Lebensqualität und Behandlungskosten. Depressive Symptome überlappen mit denen der Herzinsuffizienz, was die Diagnose erschwert. Wenig aufwendige Screening-Instrumente, z. B. der 2‑Item-Gesundheitsfrageborgen für Depression, erleichtern im klinischen Alltag die Erkennung. Bisher gibt es keine Evidenz aus randomisierten kontrollierten Studien, dass Antidepressiva bei Herzinsuffizienz Stimmung und Prognose verbessern können, sodass deren Einsatz eine Einzelfallentscheidung bleiben sollte. Durch körperliches Training, kognitive Verhaltenstherapie und multidisziplinäre ganzheitliche Betreuungskonzepte wurden in einzelnen randomisierten Studien depressive Symptome und/oder Prognose gebessert.

Rutledge T, Reis VA, Linke SE et al (2006) Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48(8):1527–1537. doi:10.1016/j.jacc.2006.06.055 CrossRefPubMed

Angermann CE, Gelbrich G, Stork S et al (2011) Somatic correlates of comorbid major depression in patients with systolic heart failure. Int J Cardiol 147(1):66–73. doi:10.1016/j.ijcard.2009.07.044 CrossRefPubMed

Faller H, Stork S, Schowalter M et al (2007) Depression and survival in chronic heart failure: Does gender play a role? Eur J Heart Fail 9(10):1018–1023. doi:10.1016/j.ejheart.2007.06.011 CrossRefPubMed

Jiang W, Kuchibhatla M, Clary GL et al (2007) Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 154(1):102–108. doi:10.1016/j.ahj.2007.03.043 CrossRefPubMed

Sherwood A, Blumenthal JA, Trivedi R et al (2007) Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 167(4):367–373. doi:10.1001/archinte.167.4.367 CrossRefPubMed

Moraska AR, Chamberlain AM, Shah ND et al (2013) Depression, healthcare utilization, and death in heart failure: A community study. Circ Heart Fail 6(3):387. doi:10.1161/CIRCHEARTFAILURE.112.000118 CrossRefPubMedPubMedCentral

Lichtman JH, Bigger JT Jr., Blumenthal JA et al (2008) Depression and coronary heart disease: recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 118(17):1768–1775. doi:10.1161/CIRCULATIONAHA.108.190769 CrossRefPubMed

Woltz PC, Chapa DW, Friedmann E et al (2012) Effects of interventions on depression in heart failure: A systematic review. Heart Lung 41(5):469–483. doi:10.1016/j.hrtlng.2012.06.002 CrossRefPubMed

Freedland KE, Carney RM, Rich MW et al (2015) Cognitive behavior therapy for depression and self-care in heart failure patients: A randomized clinical trial. JAMA Intern Med 175(11):1773–1782. doi:10.1001/jamainternmed.2015.5220 CrossRefPubMedPubMedCentral

10.

Blumenthal JA, Babyak MA, O’Connor C et al (2012) Effects of exercise training on depressive symptoms in patients with chronic heart failure: The HF-ACTION randomized trial. JAMA 308(5):465–474. doi:10.1001/jama.2012.8720 CrossRefPubMedPubMedCentral

11.

World Health Organization (1992) ICD-10 Classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. World Health Organization, Geneva

12.

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). American Psychiatric Publishing, Arlington VACrossRef

13.

Lowe B, Kroenke K, Grafe K (2005) Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 58(2):163–171. doi:10.1016/j.jpsychores.2004.09.006 CrossRefPubMed

14.

Piepenburg SM, Faller H, Gelbrich G et al (2015) Comparative potential of the 2‑item versus the 9‑item patient health questionnaire to predict death or rehospitalization in heart failure. Circ Heart Fail 8(3):464–472. doi:10.1161/CIRCHEARTFAILURE.114.001488 CrossRefPubMed

15.

American Heart Association (2005) Heart disease and stroke statistics – 2005 update. American Heart Association, Dallas

16.

Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 93(9):1137–1146. doi:10.1136/hrt.2003.025270 CrossRefPubMedPubMedCentral

17.

Vos T, Flaxman AD, Naghavi M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2163–2196. doi:10.1016/S0140-6736(12)61729-2 CrossRefPubMed

18.

Busch MA, Maske UE, Ryl L et al (2013) Prevalence of depressive symptoms and diagnosed depression among adults in Germany: Results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(5–6):733–739. doi:10.1007/s00103-013-1688-3 CrossRefPubMed

19.

Vaccarino V, Kasl SV, Abramson J (2001) Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 38(1):199–205CrossRefPubMed

20.

Faller H, Stork S, Schowalter M et al (2007) Is health-related quality of life an independent predictor of survival in patients with chronic heart failure? J Psychosom Res 63(5):533–538. doi:10.1016/j.jpsychores.2007.06.026 CrossRefPubMed

21.

Klempfner R, Koifman E, Goldenberg I et al (2014) The Israel Nationwide Heart Failure Survey: Sex differences in early and late mortality for hospitalized heart failure patients. J Card Fail 20(3):193–198. doi:10.1016/j.cardfail.2013.12.016 CrossRefPubMed

22.

Brandsaeter B, Atar D, Agewall S et al (2011) Gender differences among Norwegian patients with heart failure. Int J Cardiol 146(3):354–358. doi:10.1016/j.ijcard.2009.07.014 CrossRefPubMed

23.

Lossnitzer N, Herzog W, Stork S et al (2012) Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol 167(2):502–507. doi:10.1016/j.ijcard.2012.01.062 CrossRefPubMed

24.

Havranek EP, Spertus JA, Masoudi FA et al (2004) Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 44(12):2333–2338. doi:10.1016/j.jacc.2004.09.034 CrossRefPubMed

25.

Luijendijk HJ, Tiemeier H, van den Berg JF et al (2010) Heart failure and incident late-life depression. J Am Geriatr Soc 58(8):1441–1448. doi:10.1111/j.1532-5415.2010.02921.x CrossRefPubMed

26.

Hare DL, Toukhsati SR, Johansson P (2014) Depression and cardiovascular disease: A clinical review. Eur Heart J 35(21):1365–1372. doi:10.1093/eurheartj/eht462 CrossRefPubMed

27.

Carney RM, Freedland KE, Veith RC (2005) Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 67(Suppl):S29–S33. doi:10.1097/01.psy.0000162254.61556.d5 CrossRefPubMed

28.

Rozanski A, Blumenthal JA, Davidson KW et al (2005) The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: The emerging field of behavioral cardiology. J Am Coll Cardiol 45(5):637–651. doi:10.1016/j.jacc.2004.12.005 CrossRefPubMed

29.

Kliks BR, Burgess MJ, Abildskov JA (1975) Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion. Am J Cardiol 36(1):45–49CrossRefPubMed

30.

Schwartz PJ (1998) The autonomic nervous system and sudden death. Eur Heart J 19(Suppl F):F72–F80PubMed

31.

Yamaji M, Tsutamoto T, Kawahara C et al (2009) Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: The impact of oxidative stress. Circ Heart Fail 2(6):608–615. doi:10.1161/CIRCHEARTFAILURE.109.868513 CrossRefPubMed

32.

Wulsin LR, Singal BM (2003) Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 65(2):201–210CrossRefPubMed

33.

Fan H, Yu W, Zhang Q et al (2014) Depression after heart failure and risk of cardiovascular and all-cause mortality: A meta-analysis. Prev Med 63:36–42. doi:10.1016/j.ypmed.2014.03.007 CrossRefPubMed

34.

Song EK, Moser DK, Kang SM (2015) Association of depressive symptoms and micronutrient deficiency with cardiac event-free survival in patients with heart failure. J Card Fail 21(12):945–951. doi:10.1016/j.cardfail.2015.10.007 CrossRefPubMed

35.

Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891–975. doi:10.1002/ejhf.592 CrossRefPubMed

36.

Jiang W, Alexander J, Christopher E et al (2001) Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161(15):1849–1856CrossRefPubMed

37.

Freedland KE, Carney RM, Rich MW et al (2016) Depression and multiple Rehospitalizations in patients with heart failure. Clin Cardiol 39(5):257–262. doi:10.1002/clc.22520 CrossRefPubMed

38.

Frasure-Smith N, Lesperance F, Habra M et al (2009) Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 120(2):134–140 (133p following 140) doi:10.1161/CIRCULATIONAHA.109.851675 CrossRefPubMed

39.

Freedland KE, Hesseler MJ, Carney RM et al (2016) Major depression and long-term survival of patients with heart failure. Psychosom Med:1. doi:10.1097/PSY.0000000000000346

40.

Beach SR, Januzzi JL, Mastromauro CA et al (2013) Patient health questionnaire-9 score and adverse cardiac outcomes in patients hospitalized for acute cardiac disease. J Psychosom Res 75(5):409–413. doi:10.1016/j.jpsychores.2013.08.001 CrossRefPubMed

41.

Jiang W, Krishnan R, Kuchibhatla M et al (2011) Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study). Am J Cardiol 107(4):545–551. doi:10.1016/j.amjcard.2010.10.013 CrossRefPubMedPubMedCentral

42.

Cohen HW, Gibson G, Alderman MH (2000) Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. Am J Med 108(1):2–8CrossRefPubMed

43.

Wallenborn J, Angermann CE (2014) Herzinsuffizienz und Depression – Eine Wechselbeziehung mit vielfältigen Facetten. Klinikarzt 43(11):524–528CrossRef

44.

Piepenburg SM, Ertl G, Angermann CE (2016) Depression und Herzinsuffizienz – eine gefährliche Kombination. Dtsch Med Wochenschr 141(17):1222–1227CrossRefPubMed

45.

O’Connor CM, Jiang W, Kuchibhatla M et al (2010) Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56(9):692–699. doi:10.1016/j.jacc.2010.03.068 CrossRefPubMedPubMedCentral

46.

Angermann CE, Gelbrich G, Stork S et al (2016) Effect of Escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial. JAMA 315(24):2683–2693. doi:10.1001/jama.2016.7635 CrossRefPubMed

47.

Gary RA, Dunbar SB, Higgins MK et al (2010) Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure. J Psychosom Res 69(2):119–131. doi:10.1016/j.jpsychores.2010.01.013 CrossRefPubMedPubMedCentral

48.

Huffman JC, Mastromauro CA, Beach SR et al (2014) Collaborative care for depression and anxiety disorders in patients with recent cardiac events: The Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. JAMA Intern Med 174(6):927–935. doi:10.1001/jamainternmed.2014.739 CrossRefPubMed

49.

Piepoli MF, Conraads V, Corra U et al (2011) Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail 13(4):347–357. doi:10.1093/eurjhf/hfr017 CrossRefPubMed

50.

McAlister FA, Lawson FM, Teo KK (2001) A systematic review of randomized trials of disease management programs in heart failure. Am J Med 110(5):378–384CrossRefPubMed

51.

Angermann CE, Stork S, Gelbrich G et al (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: The Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 5(1):25–35. doi:10.1161/CIRCHEARTFAILURE.111.962969 CrossRefPubMed

52.

Koehler F, Winkler S, Schieber M et al (2012) Telemedicine in heart failure: Pre-specified and exploratory subgroup analyses from the TIM-HF trial. Int J Cardiol 161(3):143–150. doi:10.1016/j.ijcard.2011.09.007 CrossRefPubMed

53.

Gunold H, Angermann CE (2015) Kognitive Dysfunktion, Depression und Angst bei Herzinsuffizienz. Aktuel Kardol 2015(4):379–386

54.

Glassman AH et al (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288:701–709CrossRefPubMed

55.

Berkman LF et al (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289:3106–3116CrossRefPubMed

56.

Lespérance F et al (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297:367–379CrossRefPubMed

57.

Van den Brink RH et al (2002) Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: Rationale and outline of the Myocardial Infarction and Depression-Intervention Trial (MIND-IT). Am Heart J 144:219–225CrossRefPubMed

Titel: Depression und Herzinsuffizienz – doppeltes Risiko?
Diagnostik, prognostische Bedeutung und Therapie einer unterschätzten Komorbidität
verfasst von: J. Wallenborn
Prof. Dr. med. C. E. Angermann
Publikationsdatum: 17.10.2016
Verlag: Springer Medizin
Schlagwörter: Herzinsuffizienz
Affektive Störungen
Herzerkrankungen und Komorbidität
Erschienen in: Herz / Ausgabe 8/2016
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-016-4483-8

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

Neuerungen der ESC-Leitlinien zur akuten und chronischen Herzinsuffizienz 2016

Heme oxygenase 1 induction protects myocardiac cells against hypoxia/reoxygenation-induced apoptosis

Die Suche nach dem Ariadnefaden im Leitlinienlabyrinth

ESC-Leitlinie zum Vorhofflimmern – die wichtigsten Neuerungen

Erratum zu: Bildgebung bei struktureller Herzerkrankung

Das Wichtigste aus dem ESC-Positionspapiers „Krebsbehandlung und kardiovaskuläre Toxizität“